{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:41:46Z","timestamp":1790991706738,"version":"4.1.0"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.4103\/1673-5374.371400","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:13:07Z","timestamp":1684411987000},"page":"2357-2364","source":"Crossref","is-referenced-by-count":36,"title":["An overview on CV2\/CRMP5 antibody-associated paraneoplastic neurological syndromes"],"prefix":"10.4103","volume":"18","author":[{"given":"Sai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiman","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"R1-20230518","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10072-015-2113-5","article-title":"Paraneoplastic cerebellar degeneration with anti-CV2\/CRMP5 antibodies and prostate adenocarcinoma","volume":"36","author":"Aliprandi","year":"2015","journal-title":"Neurol Sci"},{"key":"R2-20230518","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(93)90176-Y","article-title":"Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina","volume":"117","author":"Antoine","year":"1993","journal-title":"J Neurol Sci"},{"key":"R3-20230518","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"key":"R4-20230518","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(85)90107-2","article-title":"Paraneoplastic myelopathy:antibodies against protein in normal spinal cord and underlying neoplasm","volume":"2","author":"Babikian","year":"1985","journal-title":"Lancet"},{"key":"R5-20230518","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00019052-200402000-00003","article-title":"Neuro-ophthalmology and paraneoplastic syndromes","volume":"17","author":"Bataller","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"R6-20230518","doi-asserted-by":"crossref","first-page":"116804","DOI":"10.1016\/j.jns.2020.116804","article-title":"Absent well-characterized onconeural antibodies in 283 patients with various polyneuropathies:A retrospective monocenter study","volume":"413","author":"Berger","year":"2020","journal-title":"J Neurol Sci"},{"key":"R7-20230518","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/CCO.0000000000000479","article-title":"Neurological paraneoplastic syndromes:an update","volume":"30","author":"Berzero","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"R8-20230518","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00259-021-05299-y","article-title":"Brain (18)F-FDG PET for the diagnosis of autoimmune encephalitis:a systematic review and a meta-analysis","volume":"48","author":"Bordonne","year":"2021","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"R9-20230518","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.20465","article-title":"Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain","volume":"486","author":"Bretin","year":"2005","journal-title":"J Comp Neurol"},{"key":"R10-20230518","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.yexcr.2012.12.011","article-title":"Identification of a new CRMP5 isoform present in the nucleus of cancer cells and enhancing their proliferation","volume":"319","author":"Brot","year":"2013","journal-title":"Exp Cell Res"},{"key":"R11-20230518","doi-asserted-by":"crossref","first-page":"E529","DOI":"10.1503\/cmaj.181548","article-title":"Diagnosing autoimmune limbic encephalitis","volume":"191","author":"Budhram","year":"2019","journal-title":"CMAJ"},{"key":"R12-20230518","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/NEN.0b013e31824d1df2","article-title":"The collapsin response mediator protein 5 onconeural protein is expressed in Schwann cells under axonal signals and regulates axon-Schwann cell interactions","volume":"71","author":"Camdessanch\u00e9","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"R13-20230518","doi-asserted-by":"crossref","first-page":"102789","DOI":"10.1016\/j.msard.2021.102789","article-title":"Simultaneous bilateral optic neuropathy and myelitis revealing paraneoplastic neurological syndrome associated with multiple onconeuronal antibodies","volume":"49","author":"Carette","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"R14-20230518","first-page":"732","article-title":"Peripheral neuropathy:evaluation and differential diagnosis","volume":"102","author":"Castelli","year":"2020","journal-title":"Am Fam Physician"},{"key":"R15-20230518","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2019.09.012","article-title":"Collapsin response-mediator protein 5-associated retinitis, vitritis, and optic disc edema","volume":"127","author":"Cohen","year":"2020","journal-title":"Ophthalmology"},{"key":"R16-20230518","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"key":"R17-20230518","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R18-20230518","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N Engl J Med"},{"key":"R19-20230518","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clineuro.2018.05.010","article-title":"Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2\/CRMP-5 antibodies in a patient with small cell lung cancer","volume":"170","author":"Dericioglu","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"R20-20230518","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"R21-20230518","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","article-title":"Devic's syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies","volume":"78","author":"Ducray","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R22-20230518","doi-asserted-by":"crossref","first-page":"761354","DOI":"10.3389\/fimmu.2021.761354","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in children:a retrospective analysis of 35 cases","volume":"12","author":"Fang","year":"2021","journal-title":"Front Immunol"},{"key":"R23-20230518","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurol.2021.04.009","article-title":"Spinal cord tractopathy in paraneoplastic anti-CV2\/CRMP5 myelitis responsive to plasma exchange","volume":"178","author":"Flabeau","year":"2022","journal-title":"Rev Neurol (Paris)"},{"key":"R24-20230518","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.0b013e31821f468f","article-title":"Paraneoplastic isolated myelopathy:clinical course and neuroimaging clues","volume":"76","author":"Flanagan","year":"2011","journal-title":"Neurology"},{"key":"R25-20230518","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ncl.2012.09.001","article-title":"Paraneoplastic myelopathy","volume":"31","author":"Flanagan","year":"2013","journal-title":"Neurol Clin"},{"key":"R26-20230518","doi-asserted-by":"crossref","first-page":"37957","DOI":"10.1074\/jbc.M003277200","article-title":"Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family","volume":"275","author":"Fukada","year":"2000","journal-title":"J Biol Chem"},{"key":"R27-20230518","doi-asserted-by":"crossref","first-page":"576980","DOI":"10.1016\/j.jneuroim.2019.576980","article-title":"A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes","volume":"334","author":"Gill","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R28-20230518","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database:a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch Neurol"},{"key":"R29-20230518","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"R30-20230518","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R31-20230518","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"R32-20230518","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R33-20230518","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis:a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol"},{"key":"R34-20230518","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.483","article-title":"Anti-CV2\/CRMP5 paraneoplastic chorea effectively managed with intravenous amantadine","author":"Ha","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"R35-20230518","doi-asserted-by":"crossref","first-page":"e235668","DOI":"10.1136\/bcr-2020-235668","article-title":"Paraneoplastic subacute sensory neuropathy with triple positive antineuronal antibodies associated with small-cell lung cancer","volume":"13","author":"Hean","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R36-20230518","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.1270","article-title":"Are the \u201cnewly discovered\u201dparaneoplastic anticollapsin response-mediator protein 5 antibodies simply anti-CV2 antibodies?","volume":"50","author":"Honnorat","year":"2001","journal-title":"Ann Neurol"},{"key":"R37-20230518","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R38-20230518","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R39-20230518","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpn.2014.12.012","article-title":"An 8-year old boy with continuous spikes and waves during slow sleep presenting with positive onconeuronal antibodies","volume":"19","author":"Hu","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"R40-20230518","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000505232","article-title":"Paraneoplastic limbic encephalitis associated with anti-CV2\/CRMP5 antibodies secondary to thymoma in an adolescent","volume":"12","author":"Ibrahim Ismail","year":"2020","journal-title":"Case Rep Neurol"},{"key":"R41-20230518","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease:case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"R42-20230518","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajhg.2021.04.004","article-title":"Missense variants in DPYSL5 cause a neurodevelopmental disorder with corpus callosum agenesis and cerebellar abnormalities","volume":"108","author":"Jeanne","year":"2021","journal-title":"Am J Hum Genet"},{"key":"R43-20230518","doi-asserted-by":"crossref","first-page":"e01528","DOI":"10.1002\/brb3.1528","article-title":"Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies:A case report and literature review","volume":"10","author":"Jia","year":"2020","journal-title":"Brain Behav"},{"key":"R44-20230518","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.21324","article-title":"Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G","volume":"63","author":"Keegan","year":"2008","journal-title":"Ann Neurol"},{"key":"R45-20230518","doi-asserted-by":"crossref","first-page":"e232656","DOI":"10.1136\/bcr-2019-232656","article-title":"Rare case: paraneoplastic syndrome affecting peripheral nerves, associated with anti-collapsin-response mediator protein-5 (anti-CRMP5) antibodies, as early manifestation of small cell lung cancer confined to a solitary lymph node without evidence of lung mass on routine CT thorax","volume":"13","author":"Khan","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R46-20230518","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2019.4379","article-title":"CRMP5-IgG-associated paraneoplastic myelopathy with PD-L1 inhibitor therapy","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"R47-20230518","doi-asserted-by":"crossref","first-page":"829076","DOI":"10.3389\/fneur.2022.829076","article-title":"Autoimmune and paraneoplastic chorea:a review of the literature","volume":"13","author":"Kyle","year":"2022","journal-title":"Front Neurol"},{"key":"R48-20230518","doi-asserted-by":"crossref","first-page":"e0696","DOI":"10.1097\/MD.0000000000010696","article-title":"Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5\/CV2 and anti-GABAB receptor antibodies in small cell lung cancer:A case report","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R49-20230518","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.08.017","article-title":"Paraneoplastic autoimmune movement disorders","volume":"44","author":"Lim","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"R50-20230518","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0028-3886.121941","article-title":"Paraneoplastic CRMP-5 basal ganglionitis and limbic encephalitis in an elderly Indian lady","volume":"61","author":"Maramattom","year":"2013","journal-title":"Neurol India"},{"key":"R51-20230518","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/MNM.0000000000000163","article-title":"Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings","volume":"35","author":"Masangkay","year":"2014","journal-title":"Nucl Med Commun"},{"key":"R52-20230518","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneurol.2009.336","article-title":"Positron emission tomography-computed tomography in paraneoplastic neurologic disorders:systematic analysis and review","volume":"67","author":"McKeon","year":"2010","journal-title":"Arch Neurol"},{"key":"R53-20230518","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.2008.149336","article-title":"CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis","volume":"80","author":"Monstad","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R54-20230518","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00262-007-0369-1","article-title":"CRMP5 antibodies in patients with small-cell lung cancer or thymoma","volume":"57","author":"Monstad","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R55-20230518","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/mds.20570","article-title":"Paraneoplastic chorea with leukoencephalopathy presenting with obsessive-compulsive and behavioral disorder","volume":"20","author":"Muehlschlegel","year":"2005","journal-title":"Mov Disord"},{"key":"R56-20230518","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2169\/internalmedicine.9736-17","article-title":"CV2\/CRMP5-antibody-related paraneoplastic optic neuropathy associated with small-cell lung cancer","volume":"57","author":"Nakajima","year":"2018","journal-title":"Intern Med"},{"key":"R57-20230518","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0039-3402061","article-title":"Autoimmune vestibulocerebellar syndromes","volume":"40","author":"Narayan","year":"2020","journal-title":"Semin Neurol"},{"key":"R58-20230518","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.0b013e3182886991","article-title":"Autoimmune chorea in adults","volume":"80","author":"O'Toole","year":"2013","journal-title":"Neurology"},{"key":"R59-20230518","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/jcm11061537","article-title":"Additional value of [18F]FDG PET\/CT in detection of suspected malignancy in patients with paraneoplastic neurological syndromes having negative results of conventional radiological imaging","volume":"11","author":"Opali\u0144ska","year":"2022","journal-title":"J Clin Med"},{"key":"R60-20230518","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1515\/revneuro-2017-0081","article-title":"Paraneoplastic movement disorders","volume":"29","author":"Pop\u0142awska-Domaszewicz","year":"2018","journal-title":"Rev Neurosci"},{"key":"R61-20230518","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R62-20230518","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.eye.6702959","article-title":"Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG:intravitreal triamcinolone acetonide therapy of four eyes","volume":"22","author":"Pulido","year":"2008","journal-title":"Eye (Lond)"},{"key":"R63-20230518","doi-asserted-by":"crossref","first-page":"858766","DOI":"10.3389\/fimmu.2022.858766","article-title":"Coexistence of multiple anti-neuronal antibodies in autoimmune encephalitis in China:A multi-center study","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Immunol"},{"key":"R64-20230518","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/resp.12292","article-title":"Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease","volume":"19","author":"Qvale","year":"2014","journal-title":"Respirology"},{"key":"R65-20230518","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/CRIAI:19:1:51","article-title":"Anti-CV2 autoantibodies and paraneoplastic neurological syndromes","volume":"19","author":"Rogemond","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"key":"R66-20230518","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11864-013-0249-1","article-title":"Diagnosis and management of paraneoplastic neurologic disorders","volume":"14","author":"Rosenfeld","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"R67-20230518","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fimmu.2020.01482","article-title":"The diagnostic value of onconeural antibodies depends on how they are tested","volume":"11","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Front Immunol"},{"key":"R68-20230518","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2015.11.009","article-title":"Pitfalls in the detection of CV2 (CRMP5) antibodies","volume":"290","author":"Sabater","year":"2016","journal-title":"J Neuroimmunol"},{"key":"R69-20230518","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11060-009-0022-2","article-title":"Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma","volume":"97","author":"Saloustros","year":"2010","journal-title":"J Neurooncol"},{"key":"R70-20230518","doi-asserted-by":"crossref","first-page":"673339","DOI":"10.3389\/fneur.2021.673339","article-title":"Antibody-mediated autoimmune diseases of the CNS:challenges and approaches to diagnosis and management","volume":"12","author":"Sechi","year":"2021","journal-title":"Front Neurol"},{"key":"R71-20230518","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2018.12.007","article-title":"A large screen for paraneoplastic neurological autoantibodies;diagnosis and predictive values","volume":"199","author":"Seluk","year":"2019","journal-title":"Clin Immunol"},{"key":"R72-20230518","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1212\/WNL.0000000000011218","article-title":"Paraneoplastic myeloneuropathies:clinical, oncologic, and serologic accompaniments","volume":"96","author":"Shah","year":"2021","journal-title":"Neurology"},{"key":"R73-20230518","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.1212\/NXI.0000000000001124","article-title":"Population-based epidemiology study of paraneoplastic neurologic syndromes","volume":"9","author":"Shah","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R74-20230518","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2169\/internalmedicine.7190-21","article-title":"Spontaneous regression of small cell lung carcinoma and associated hemichorea","volume":"60","author":"Shibata","year":"2021","journal-title":"Intern Med"},{"key":"R75-20230518","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic value of (18)F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J Nucl Med"},{"key":"R76-20230518","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12883-021-02448-6","article-title":"Parkinsonism and dysautonomia with anti-CV2\/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy:a case report","volume":"21","author":"Song","year":"2021","journal-title":"BMC Neurol"},{"key":"R77-20230518","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1007\/s00415-021-10934-7","article-title":"Movement disorders associated with neuronal antibodies:a data-driven approach","volume":"269","author":"Sturchio","year":"2022","journal-title":"J Neurol"},{"key":"R78-20230518","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jnnp-2015-311569","article-title":"Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia","volume":"87","author":"Tada","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R79-20230518","doi-asserted-by":"crossref","first-page":"577635","DOI":"10.1016\/j.jneuroim.2021.577635","article-title":"A paraneoplastic syndrome misdiagnosed as ALS:What are the red flags?A case report and review of the literature","volume":"358","author":"Tolkovsky","year":"2021","journal-title":"J Neuroimmunol"},{"key":"R80-20230518","doi-asserted-by":"crossref","first-page":"729075","DOI":"10.3389\/fneur.2021.729075","article-title":"CRMP5 antibodies-diagnostic challenges","volume":"12","author":"Totland","year":"2021","journal-title":"Front Neurol"},{"key":"R81-20230518","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants:classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"key":"R82-20230518","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s10072-020-04399-1","article-title":"Paraneoplastic basal ganglia encephalitis associated with anti-CV2\/CRMP-5 and anti-Yo antibodies in a patient with non-small-cell lung cancer","volume":"41","author":"Vakrakou","year":"2020","journal-title":"Neurol Sci"},{"key":"R83-20230518","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/mdc3.13019","article-title":"CRMP-5-IgG associated paraneoplastic chorea","volume":"7","author":"Vaswani","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"R84-20230518","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes:report of an EFNS Task Force","volume":"13","author":"Vedeler","year":"2006","journal-title":"Eur J Neurol"},{"key":"R85-20230518","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","article-title":"Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma","volume":"51","author":"Vernino","year":"2002","journal-title":"Ann Neurol"},{"key":"R86-20230518","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s00415-011-6074-1","article-title":"Chorea and related movement disorders of paraneoplastic origin:the PNS EuroNetwork experience","volume":"258","author":"Vigliani","year":"2011","journal-title":"J Neurol"},{"key":"R87-20230518","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(02)00135-7","article-title":"Paraneoplastic neurological syndromes:an update on diagnosis, pathogenesis, and therapy","volume":"1","author":"Voltz","year":"2002","journal-title":"Lancet Neurol"},{"key":"R88-20230518","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","journal-title":"JAMA Oncol"},{"key":"R89-20230518","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10637-021-01154-x","article-title":"Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer","volume":"40","author":"Wang","year":"2021","journal-title":"Invest New Drugs"},{"key":"R90-20230518","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1038\/s41598-020-67485-6","article-title":"Influencing electroclinical features and prognostic factors in patients with anti-NMDAR encephalitis:a cohort follow-up study in Chinese patients","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"R91-20230518","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3389\/fneur.2019.01064","article-title":"Anti-CV2 autoimmune encephalitis with parkinson-like symptoms and bilateral leukoencephalopathy-A case report","volume":"10","author":"Wu","year":"2019","journal-title":"Front Neurol"},{"key":"R92-20230518","doi-asserted-by":"crossref","first-page":"300060520974466","DOI":"10.1177\/0300060520974466","article-title":"Anti-CV2\/CRMP5 antibody-positive paraneoplastic neurological syndromes with chronic intestinal pseudo-obstruction in a small-cell lung cancer patient:a case report and literature review","volume":"48","author":"Yan","year":"2020","journal-title":"J Int Med Res"},{"key":"R93-20230518","doi-asserted-by":"crossref","first-page":"e242082","DOI":"10.1136\/bcr-2021-242082","article-title":"Paraneoplastic optic neuropathy secondary to adenocarcinoma of the lung","volume":"14","author":"Yap","year":"2021","journal-title":"BMJ Case Rep"},{"key":"R94-20230518","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody:marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann Neurol"},{"key":"R95-20230518","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer:Neurological and serological accompaniments","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thorac Cancer"},{"key":"R96-20230518","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12028-018-0536-6","article-title":"Clinical characteristics and prognosis of severe anti-N-methyl-D-aspartate receptor encephalitis patients","volume":"29","author":"Zhang","year":"2018","journal-title":"Neurocrit Care"},{"key":"R97-20230518","doi-asserted-by":"crossref","first-page":"918396","DOI":"10.3389\/fimmu.2022.918396","article-title":"Relapses of anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis:a retrospective cohort study","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"R98-20230518","doi-asserted-by":"crossref","first-page":"706169","DOI":"10.3389\/fneur.2021.706169","article-title":"Paraneoplastic neuropathies:what's new since the 2004 recommended diagnostic criteria","volume":"12","author":"Zoccarato","year":"2021","journal-title":"Front Neurol"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.371400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:08:35Z","timestamp":1787760515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.371400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.371400","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]}}}